Table 3. Experiment #1 spatiotemporal gait parameter effects and interactions.
Conditions | Effects (p values) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Dual-Task | Dual-Task | ||||||||||||||||||||
No Visual Cues | Visual Cues | No Visual Cues | Visual Cues | Group | DT | Group*DT | VC | Group* VC | Trial | Group* Trial | DT* VC | Group* DT*VC | DT* Trial | Group* DT*Trial | VC* Trial | Group* VC* Trial | DT* VC* Trials | Group* DT* VC*Trial | UPDRS | ||
Step Length (cm) | ANOVA | 0.0014 | <0.0001 | 0.061 | 0.0007 | 0.0026 | 0.0091 | 0.337 | <0.0001 | 0.717 | 0.538 | 0.256 | 0.0035 | 0.203 | 0.623 | 0.883 | |||||
ANCOVA | 0.128 | 0.214 | 0.272 | 0.187 | 0.0103 | 0.385 | 0.318 | 0.364 | 0.578 | 0.251 | 0.713 | 0.54 | 0.828 | 0.951 | 0.952 | 0.081 | |||||
Freezers | 49.23 (13.25) | 54.66 (15.12) | 41.35 (14.04) | 49.31 (18.55) | |||||||||||||||||
non-Freezers | 65.58 (8.57) | 63.46 (6.15) | 61.04 (7.48) | 64.42 (2.90) | |||||||||||||||||
Step Length Variability (CV) | ANOVA | 0.0231 | 0.0003 | 0.0153 | 0.112 | 0.435 | 0.718 | 0.51 | 0.542 | 0.935 | 0.342 | 0.977 | 0.713 | 0.578 | 0.089 | 0.625 | |||||
ANCOVA | 0.384 | 0.3 | 0.061 | 0.194 | 0.234 | 0.33 | 0.971 | 0.245 | 0.459 | 0.043 | 0.192 | 0.224 | 0.852 | 0.657 | 0.62 | 0.132 | |||||
Freezers | 12.62 (9.86) | 13.77 (15.69) | 17.75 (13.40) | 15.04 (13.66) | |||||||||||||||||
non-Freezers | 6.00 (3.61) | 5.47 (3.23) | 6.32 (2.91) | 5.48 (2.97) | |||||||||||||||||
Step Time (sec.) | ANOVA | 0.08 | 0.92 | 0.661 | <0.0001 | 0.0139 | <0.0001 | 0.0352 | 0.0292 | 0.469 | 0.0019 | 0.804 | <0.0001 | 0.103 | <0.0001 | 0.547 | |||||
ANCOVA | 0.256 | 0.418 | 0.39 | 0.0441 | 0.0333 | 0.0001 | 0.034 | 0.343 | 0.417 | 0.246 | 0.777 | 0.0434 | 0.262 | 0.281 | 0.941 | 0.785 | |||||
Freezers | 0.57 (0.09) | 0.68 (0.19) | 0.56 (0.09) | 0.64 (0.14) | |||||||||||||||||
non-Freezers | 0.55 (0.05) | 0.58 (0.06) | 0.55 (0.05) | 0.58 (0.06) | |||||||||||||||||
Step Time Variability (CV) | ANOVA | 0.0122 | 0.988 | 0.17 | 0.0026 | 0.746 | 0.005 | 0.33 | 0.0016 | 0.848 | 0.0227 | 0.235 | 0.76 | 0.355 | 0.346 | 0.474 | |||||
ANCOVA | 0.154 | 0.885 | 0.356 | 0.527 | 0.889 | 0.922 | 0.782 | 0.272 | 0.738 | 0.587 | 0.313 | 0.825 | 0.664 | 0.446 | 0.851 | 0.424 | |||||
Freezers | 7.54 (8.31) | 10.77 (7.28) | 8.55 (5.51) | 9.46 (5.77) | |||||||||||||||||
non-Freezers | 4.49 (4.56) | 5.74 (1.99) | 4.89 (2.29) | 5.42 (1.62) | |||||||||||||||||
Double Support Time Percentage (%) | ANOVA | 0.326 | <0.0001 | 0.582 | 0.0001 | 0.0299 | 0.0451 | 0.497 | 0.0001 | 0.76 | 0.077 | 0.2 | 0.128 | 0.628 | 0.735 | 0.969 | |||||
ANCOVA | 0.367 | 0.225 | 0.657 | 0.104 | 0.0432 | 0.285 | 0.214 | 0.887 | 0.393 | 0.21 | 0.134 | 0.516 | 0.838 | 0.772 | 0.828 | 0.0132 | |||||
Freezers | 36.65 (8.43) | 35.46 (10.35) | 41.22 (10.54) | 37.72 (11.92) | |||||||||||||||||
non-Freezers | 31.60 (4.81) | 31.96 (4.66) | 33.86 (4.46) | 31.67 (3.71) | |||||||||||||||||
DST% Variability (CV) | ANOVA | 0.0024 | 0.0187 | 0.321 | 0.336 | 0.646 | 0.204 | 0.524 | 0.0471 | 0.017 | 0.416 | 0.254 | 0.997 | 0.794 | 0.779 | 0.852 | |||||
ANCOVA | 0.0118 | 0.327 | 0.317 | 0.488 | 0.506 | 0.539 | 0.812 | 0.039 | 0.0048 | 0.769 | 0.336 | 0.818 | 0.75 | 0.152 | 0.384 | 0.606 | |||||
Freezers | 7.03 (4.04) | 10.11 (9.17) | 8.92 (5.72) | 8.27 (6.47) | |||||||||||||||||
non-Freezers | 5.07 (2.62) | 4.96 (3.82) | 4.24 (1.74) | 4.65 (3.00) | |||||||||||||||||
Velocity (cm/sec) | ANOVA | 0.0004 | <0.0001 | 0.154 | 0.274 | 0.0142 | <0.0001 | 0.596 | <0.0001 | 0.815 | 0.0054 | 0.31 | 0.605 | 0.708 | 0.0007 | 0.904 | |||||
ANCOVA | 0.07 | 0.983 | 0.867 | 0.965 | 0.0467 | 0.0016 | 0.173 | 0.0487 | 0.9968 | 0.0064 | 0.657 | 0.269 | 0.941 | 0.403 | 0.957 | 0.069 | |||||
Freezers | 88.26 (26.52) | 84.02 (29.12) | 74.83 (26.50) | 78.26 (29.27) | |||||||||||||||||
non-Freezers | 119.90 (20.43) | 109.51 (16.02) | 111.16 (17.19) | 112.43 (12.39) |
DT, Dual-Task; VC, Visual Cues; UPDRS-III, Unified Parkinson’s Disease Rating Scale-III; DST%, Double Support Time Percentage
* illustrates interactions between groups, conditions, and trials (referring to the statistical comparisons between subsequent trials to evaluate whether completing each condition three times influences behaviours found).